Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? - Wikidata - wikimedia - TriplyDB

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

http://www.wikidata.org/entity/Q42215146

about

Neuroimaging studies of striatum in cognition part II: Parkinson's disease Toxin-Induced Experimental Models of Learning and Memory Impairment Handedness and motor symptom asymmetry in Parkinson's disease.Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.New MRI Biomarkers Advance the Characterization of Parkinson Disease.Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation.Motor signs predict poor outcomes in Alzheimer disease.Cognitive slowing in Parkinson's disease resolves after practice.Association between presenting motor symptoms and the risk of cognitive impairment in Parkinson's disease.Frontal-subcortical circuitry and behavior.Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study).Neurotransmission in Parkinson's disease: beyond dopamine.Apathy in Parkinson's disease: an electrophysiological study.Fibrocartilaginous emboli to the spinal cord: a review of the literature.Beyond verbal fluency: investigating the long-term effects of bilateral subthalamic (STN) deep brain stimulation (DBS) on language function in two cases.Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease.Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.Which factors predict cognitive decline in Parkinson's disease?Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease.Motor impulsivity in Parkinson disease: associations with COMT and DRD2 polymorphisms.Cognitive impairment in early-stage non-demented Parkinson's disease patients.Mental and motor switching in Parkinson's disease.Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice.The role of the striatum in motor learning: dissociations between isometric motor control processes in Parkinson's disease.The feasibility and positive effects of a customised videogame rehabilitation programme for freezing of gait and falls in Parkinson's disease patients: a pilot study.Language impairment in Parkinson's disease

P2860

Q26779306-D882C14B-5E8B-4BFC-82F6-950EBDC4BEA3 Q28075913-72490999-DF95-4FDF-8554-2B02A2BFA993 Q30418038-721A7123-52D8-4486-9508-760F6C984549 Q30470435-DDEB45A4-C855-4046-B88A-DC8FECBF32C6 Q30495509-543A49AA-08A0-4BA4-BE3F-A6F8BD85F25B Q30835312-A2D4F2CC-6A70-4BD5-A614-FDC94F59550F Q33589547-0B1ECAAB-14ED-4DD2-8F86-DEB0D138959B Q34529965-B98AFEC3-3403-4696-ADD3-B20AE0C9D1DE Q35469822-F8F2FD14-D2B1-4658-AD36-E3E7B918C354 Q36863627-65C79E93-73B2-40D0-8139-39BF78E5F2A4 Q36922121-8F326C72-722A-45EE-B6E4-48A88B254087 Q37625315-8964CC2A-5868-4711-BB39-3FA90A8D7685 Q37668684-E3633DAB-229B-4562-8FA1-5A7C8D4D20CD Q37718935-B3C7B8E6-CE37-4633-8076-FD7854195DE4 Q37921302-5E72A482-FAE3-47F9-8A47-F1A854BCCF57 Q38413629-65AC818B-F88B-4889-A820-A1D4CE5FA7AC Q38478562-4E53E59C-249C-416C-8498-980675FE95B6 Q38598375-EAD90699-46B9-47A4-96A2-95B5809FDAB3 Q41876297-01CF4F6F-C9C1-4F64-9687-C4661D582C7E Q44212444-C824957A-E90E-459E-8071-84071D95489D Q46205987-23E3DB4A-8BC6-43D3-9746-6CF1C20094E3 Q48415374-AECC0D4E-8724-4B4A-ADDB-0B694634EE38 Q48695468-6AB7FE8E-2C33-43D6-B9E2-74E8FD8C0E23 Q51839227-8F266F8A-9480-463F-A732-BDA93B4C22A7 Q52215561-81C80541-87E1-4F03-8661-8B5D77E2CAC4 Q52595601-4A0F21DB-3416-4B13-8DE5-70357BAD0F33 Q58284650-470DD88D-4D6C-46FC-A353-31A4FA140E88

P2860

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

http://www.wikidata.org/entity/Q42215146

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

1989年论文

@zh

1989年论文

@zh-cn

name

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

@en

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

@nl

type

label

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

@en

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

@nl

prefLabel

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

@en

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

@nl

P1433

Q42215146-42CAD94C-100A-4B8D-9719-4EB073696BD2

P1476

Q42215146-4D66DC5D-0968-47DF-8FD0-6E77964E0872

P2093

Q42215146-7A5EF578-6868-4576-875E-B586228D61D9

Q42215146-B23D4B63-A839-48F0-AAFF-6D3CA108E4A8

Q42215146-B920D493-93AA-41A7-A358-D5E8F76B13EE

Q42215146-B9A986CC-5D47-4361-A58A-59ACDA1A05E0

Q42215146-CD2EB113-4E58-4978-8241-31BB071D14AF

P2860

Q42215146-027465E6-5A77-4E4E-8157-94C6470FEB33

Q42215146-05AAC1ED-967C-453B-85EF-6EC7C853C4CE

Q42215146-17428216-D635-45B3-A5DF-F8B06DAF4DF0

Q42215146-1B151D48-96B1-4B9A-BD23-C59653B07FC9

Q42215146-235794F1-E348-4633-BC14-51212FD6027D

Q42215146-240527C6-458C-41AD-A33F-97ACD29E04CF

Q42215146-2673CA78-0743-4B33-BCF4-CDFEFED14F6B

Q42215146-39EA0E0F-668E-4CA8-835F-C6CEC058F274

Q42215146-3DFCCCD7-2DAA-4357-A958-E7FDE5820A55

Q42215146-467D2BFE-8F63-46A8-8E90-723A5878FF93

P304

Q42215146-2734ADE4-839D-4846-9DA4-68B75B2749B6

P31

Q42215146-2146C722-C166-4719-BE28-B51609D173D1

P356

Q42215146-310E0E80-0106-483D-93BC-1E18EF73CE62

P407

Q42215146-D4C0CF1D-AC50-4D08-829A-68F2F7EF5B07

P433

Q42215146-CB63CB5E-2074-47CB-BA6E-1DCF96DE1297

P478

Q42215146-174C15B8-731B-493F-8C14-EF4EF15E9395

P50

Q42215146-9CBDDC97-CC4A-4A7D-8946-9661556D0A37

P577

Q42215146-DABE690A-EE10-4973-9FEE-217984E09AFF

P5875

Q42215146-CCFC2F23-5E73-4130-9968-7FEEA5BC7A0E

P698

Q42215146-F1135352-8E73-4B82-8657-E4C638359989

P921

Q42215146-05C3D722-33A8-4F1D-B1E4-0F6DF68C671A

Q42215146-13DD4264-2576-4C63-83B8-86C692C723F0

P932

Q42215146-40C6CC71-0249-47A6-9A94-1EB57F3AE85C

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

@en

P2093

Bonnet AM

http://www.w3.org/2001/XMLSchema#string

Cusimano G

http://www.w3.org/2001/XMLSchema#string

Dubois B

http://www.w3.org/2001/XMLSchema#string

Lhermitte F

http://www.w3.org/2001/XMLSchema#string

Pillon B

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinsonism: onset, progression and mortality

Chronic Parkinsonism secondary to intravenous injection of meperidine analogues

Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa

Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.

Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease.

Levodopa's awakening effect on patients with Parkinsonism.

Human autonomy and the frontal lobes. Part I: Imitation and utilization behavior: a neuropsychological study of 75 patients.

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow.

Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study.

P304

201-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.52.2.201

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

1989-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20452072

http://www.w3.org/2001/XMLSchema#string

P698

2703838

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

1032506

http://www.w3.org/2001/XMLSchema#string